about
Unsung Hero Robert C. GalloOpposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells.HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.V-region and class specific RT-PCR amplification of human immunoglobulin heavy and light chain genes from B-cell lines.Emergence of exhausted B cells in asymptomatic HIV-1-infected patients naïve for HAART is related to reduced immune surveillance.HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.Multicenter Evaluation of Anyplex Plus MTB/NTM MDR-TB Assay for Rapid Detection of Mycobacterium tuberculosis Complex and Multidrug-Resistant Isolates in Pulmonary and Extrapulmonary SpecimensMolecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonistsU94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesisA single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17.A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17.Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway.Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope.Detection of KI WU and Merkel cell polyomavirus in respiratory tract of cystic fibrosis patients.A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity.A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation.Detection of HIV-1 matrix protein p17 quasispecies variants in plasma of chronic HIV-1-infected patients by ultra-deep pyrosequencing.Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study.HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis.Detection of a porcine-like rotavirus in a child with enteritis in Italy.T cells from individuals in advanced stages of HIV-1 infection do not proliferate but express activation antigens in response to HIV-1-specific antigens.Long-lasting CD3+ T-cell deficiency after cord blood stem cell transplantation in a human herpesvirus 6-infected child.HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation.Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.Adult human heart microvascular endothelial cells are permissive for non-lytic infection by human cytomegalovirus.Human metapneumovirus-associated hospital admissions over five consecutive epidemic seasons: evidence for alternating circulation of different genotypes.Human metapneumovirus infection in young children hospitalized with acute respiratory tract disease: virologic and clinical features.Human herpesvirus-6 modulates RANTES production in primary human endothelial cell culturesHuman herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1-dependent capillary-like structure formation: role of the IKK/NF- B pathwayCD8+CD28- T Lymphocytes from HIV-1-Infected Patients Secrete Factors That Induce Endothelial Cell Proliferation and Acquisition of Kaposi's Sarcoma Cell FeaturesPhenotypic and functional characteristics of tumour-derived microvascular endothelial cellsHIV-1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokinesHuman cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factorA monoclonal antibody to the NH2-terminal region of human interferon-gamma inhibits its antiproliferative activity without affecting its internalizationHeat-killed Bacillus subtilis inhibits T-cell proliferative response to mitogens and recall antigensLack of polarized type 1 or type 2 cytokine profile in asymptomatic HIV-1-infected patients during a two-year bimonthly follow-upHIV p17 enhances lymphocyte proliferation and HIV-1 replication after binding to a human serum factorReduced production of both Th1 and Tc1 lymphocyte subsets in atopic dermatitis (AD)
P50
Q22065525-E6B7D204-42DA-4059-8330-CAFEC8F0217EQ33851786-CDF29593-CAF2-487E-8980-8D497B6B1D3DQ34098372-E273E743-8B03-4EBE-9047-EE84135A0BD4Q34296383-FD2B033D-1473-4F18-9E3D-24CD968F2298Q35830092-CE0C1A94-34C8-427E-B06B-A934AB6B0DEAQ36221840-09DB8C44-F35D-4D45-8DA8-0D2AB05B6728Q36306025-02E78517-211F-491A-A5BD-B06C0CA09294Q36434491-A5609605-B8BD-4744-A3C4-10827AC14582Q36526260-E976FCCD-276A-45D5-96E3-A77931D976B0Q37453582-EB586132-7CF6-4C20-BF48-D900646FA9F4Q38659232-3EAB67FE-6665-4C52-AFDD-295A984D5CEDQ38907078-423FAA5B-FB07-424C-A5B6-DA57285289D1Q40428203-A3AB9A98-40ED-4C26-B9E0-A7E6ACE0EC1EQ40486626-6292C5C8-8FF9-403A-AEFD-581A1ED7F2EFQ40854172-BA2AE367-94DF-4E0C-B684-7167385D6BAFQ41486068-22F191D0-671D-482B-A19F-39D51797456AQ42200074-404C0DBE-F3C3-49DD-BE43-0B178C482489Q42205220-4604DE4D-4400-4F13-B3E6-093DA6ABCF7CQ42219369-74BFE94F-C80F-4E47-951F-A0FE6A8AD618Q42231663-FA6A0462-9D8C-4A6E-96D8-58280F74ED79Q42239854-9F5BE083-4B78-4052-B048-772E201F2EC8Q42265113-10A97907-F16B-437B-B67A-09C302085DACQ42659959-E53A0636-26F4-458A-A9B1-8A05CB851F65Q42722120-BB87FFCC-3216-457A-A4DC-BD617597FF85Q42722260-4F9F46BF-5CAD-4E41-9F27-21D351F8AA2FQ43284733-42C5063A-E672-419D-AD46-5E4E95D0F1FCQ43960272-97FFF0B0-0433-4A80-86D7-BC0D9216B8C1Q44612082-F90548E1-DA79-4172-9102-5A30B930AD89Q54539365-C45EB526-198D-4EE3-BF34-267220CAC327Q57583823-2F11A3BE-8ED0-440C-9B9B-CDAA515E1001Q58620073-92FFF64C-CAB5-468F-8FF8-8EA0CBC8A703Q59647825-312411CF-1904-4219-9952-7B3B36B0EB4EQ60043738-B114B208-F6AF-4BEB-BE67-39BE47554EF7Q60684998-DF32C5B6-9A8E-45C7-8E7A-D6DFCD6889F1Q61185965-0C60ADC5-FF6D-404B-B401-F49AA3B7905AQ71801685-E7F8F9A3-ADA7-4147-BD12-1CDB16BCCCC8Q73388561-F1A942F8-F115-4F9D-9AA5-56BDD30C02BAQ74297356-C2888831-4569-46B4-9994-D7EE39D36333Q74364937-7CEB9EA1-3D2D-41D9-8380-93A2BF9BB6AAQ77953317-8E94FDEA-0A5C-45C4-8AC7-6A3093CF78C9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Simona Fiorentini
@ast
Simona Fiorentini
@en
Simona Fiorentini
@es
Simona Fiorentini
@nl
type
label
Simona Fiorentini
@ast
Simona Fiorentini
@en
Simona Fiorentini
@es
Simona Fiorentini
@nl
prefLabel
Simona Fiorentini
@ast
Simona Fiorentini
@en
Simona Fiorentini
@es
Simona Fiorentini
@nl
P106
P1153
16179902300
P21
P31
P496
0000-0002-1866-314X